Guardant Health Inc
NASDAQ:GH

Watchlist Manager
Guardant Health Inc Logo
Guardant Health Inc
NASDAQ:GH
Watchlist
Price: 101.74 USD -0.39% Market Closed
Market Cap: 13.1B USD

Operating Margin
Guardant Health Inc

-48.1%
Current
-87%
Average
3.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-48.1%
=
Operating Profit
-433.7m
/
Revenue
902.6m

Operating Margin Across Competitors

No Stocks Found

Guardant Health Inc
Glance View

Market Cap
12.7B USD
Industry
Health Care

Guardant Health Inc. emerged from the convergence of innovation and necessity, pioneering a transformative approach to cancer diagnostics. Founded in 2012 by Helmy Eltoukhy and AmirAli Talasaz, the company focuses on the potential of liquid biopsy technology. Unlike traditional biopsies that often require invasive procedures, Guardant Health's tests analyze circulating tumor DNA (ctDNA) from a simple blood draw. This standout technology not only provides critical insights into the genomic profile of tumors but also facilitates early cancer detection, treatment monitoring, and recurrence detection, breaking new grounds in precision oncology. The company's flagship product, Guardant360, plays a pivotal role for oncologists by enabling tailored treatment plans based on real-time, dynamic insights into the cancer's genetic mutations. Earning its revenue primarily through partnerships with healthcare providers, pharmaceutical companies, and research institutions, Guardant Health has positioned itself strategically in the medical diagnostics landscape. By offering tests that can be repeatedly adapted to monitor the evolution of cancer over time, the company garners significant interest as it aids in the development of targeted cancer therapies. Pharmaceutical companies, in particular, collaborate with Guardant Health to utilize its technology in clinical trials to identify suitable candidates and assess treatment efficacy. The company's growing influence is further bolstered by its commitment to expanding applications for early cancer detection, laying the groundwork for potential shifts in cancer care paradigms. Thus, Guardant Health, through its innovative fusions of technology and healthcare, forges ahead in transforming cancer management and diagnostics, turning its story into a testament of modern medical advancement.

GH Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-48.1%
=
Operating Profit
-433.7m
/
Revenue
902.6m
What is the Operating Margin of Guardant Health Inc?

Based on Guardant Health Inc's most recent financial statements, the company has Operating Margin of -48.1%.

Back to Top